Covalent fragment-based drug discovery as a strategy to combat leishmaniasis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Covalent inhibition has emerged as a powerful strategy in drug discovery, offering a unique combination of potency, selectivity, and sustained target engagement.Building on our previous findings-where we identified barbituric acid derivatives as orotate bioisosteres that, upon introduction of an exocyclic double bond, acted as covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (LbDHODH)-we now report a new series of conjugated dienebarbituric acid compounds derived from the most potent previously identified inhibitor, 2i, a nanomolar compound with antiparasitic activity.
Fields of Study & Subjects
Research on Leishmaniasis Studies
Synthesis and Characterization of Heterocyclic Compounds
Heterocyclic Compound Synthesis and Bioactivity
Publication details
- Journal / source
- Acta Crystallographica Section A Foundations and Advances
- Volume
- 81
- Issue
- a1
- Pages
- e45–e45
- Publication date
- 30 March 2026
- Language
- EN